Ulrich Reinhold Speck
Chief Tech/Sci/R&D Officer presso ACOTEC SCIENTIFIC HOLDINGS LIMITED
Profilo
Ulrich Reinhold Speck is the founder of InnoRa GmbH, which was founded in 2001.
He held the title of Managing Director & Legal Representative from 2001 to 2017.
Currently, he is the Chief Technology Officer at Acotec Scientific Holdings Ltd.
since 2021.
Previously, he worked as a Professor at Charité - Universitätsmedizin Berlin from 2000 to 2001.
Dr. Speck received his doctorate degree from Freie Universität Berlin in 1967.
Posizioni attive di Ulrich Reinhold Speck
Società | Posizione | Inizio |
---|---|---|
ACOTEC SCIENTIFIC HOLDINGS LIMITED | Chief Tech/Sci/R&D Officer | 29/01/2021 |
Precedenti posizioni note di Ulrich Reinhold Speck
Società | Posizione | Fine |
---|---|---|
InnoRa GmbH
InnoRa GmbH Medical/Nursing ServicesHealth Services InnoRa GmbH is a German company that specializes in randomized clinical trials and contributions to product development. The private company is based in Berlin, Germany. The company focuses on developing coated balloons, devices, and therapeutics for restenosis inhibition by non-stent-based local drug delivery. In addition, they conduct clinical trials and research in pharmacology, pharmacokinetics, bioanalytics, relaxometry, and molecular imaging. The company was founded in 2001 by Ulrich Reinhold Speck. Thomas Speck has been the CEO of the company since 2011. | Founder | 18/01/2017 |
Charité - Universitätsmedizin Berlin | Corporate Officer/Principal | 01/01/2001 |
Formazione di Ulrich Reinhold Speck
Freie Universität Berlin | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ACOTEC SCIENTIFIC HOLDINGS LIMITED | Health Technology |
Aziende private | 1 |
---|---|
InnoRa GmbH
InnoRa GmbH Medical/Nursing ServicesHealth Services InnoRa GmbH is a German company that specializes in randomized clinical trials and contributions to product development. The private company is based in Berlin, Germany. The company focuses on developing coated balloons, devices, and therapeutics for restenosis inhibition by non-stent-based local drug delivery. In addition, they conduct clinical trials and research in pharmacology, pharmacokinetics, bioanalytics, relaxometry, and molecular imaging. The company was founded in 2001 by Ulrich Reinhold Speck. Thomas Speck has been the CEO of the company since 2011. | Health Services |
- Borsa valori
- Insiders
- Ulrich Reinhold Speck